Haoyue Sheng

1.0k citations
21 papers · 702 indexed · h-index 14
Topics
Bladder and Urothelial Cancer Treatments (4 papers)Ferroptosis and cancer prognosis (4 papers)Cancer-related molecular mechanisms research (4 papers)
Partner nations
ChinaUnited StatesCanada

In The Last Decade

Haoyue Sheng

20 papers receiving 696 citations

Peers

Haoyue Sheng
Comparison fields: 5 of 83
  • Molecular Biology 457
  • Cancer Research 274
  • Pulmonary and Respiratory Medicine 129
  • Oncology 105
  • Immunology 67
Replace Kanthida Kusonmano with:
Kanthida Kusonmano Thailand
Cheng Zeng China
Ling Wei China
Xiaoqian Zhang China
Pengyun Qiao China
Gerard A. Tarulli Australia
Yixia Yang China
Laura San‐Segundo Spain
An Xu China
Haoyue Sheng relative to Kanthida Kusonmano Thailand Kanthida Kusonmano's profile →
Citations per field
00.5×1.5×
Kanthida Kusonmano · 1×
Citations per year

Countries citing papers authored by Haoyue Sheng

Since Specialization
Citations

This map shows the geographic impact of Haoyue Sheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haoyue Sheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haoyue Sheng more than expected).

Fields of papers citing papers by Haoyue Sheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haoyue Sheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haoyue Sheng. The network helps show where Haoyue Sheng may publish in the future.

Co-authorship network of co-authors of Haoyue Sheng

This figure shows the co-authorship network connecting the top 25 collaborators of Haoyue Sheng. A scholar is included among the top collaborators of Haoyue Sheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haoyue Sheng. Haoyue Sheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 30
3 5
4 54
5 62
6 17
7 3
8 18
9 4
10 20
11 214
12 37
13 13
14 9
15 4
16 13
17 18
18 81
19 16
20 58

About Haoyue Sheng

Haoyue Sheng is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 21 papers that have together received 702 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (4 papers), Ferroptosis and cancer prognosis (4 papers) and Cancer-related molecular mechanisms research (4 papers). The work is most often cited by research in Cancer Research (274 citations), Molecular Biology (457 citations) and Pollution (49 citations). Haoyue Sheng has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Guohai Shi, Qiupeng Zheng, Hong Zhou, Zongze Shao, Chunming Dong, Lingxia Jiao, Haojie Huang, Liguo Wang, Xiaohong Cai and Yuchen Li. Their work appears in journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026